| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2022 | 12.9% | RBC Capital | $11 → $7 | Maintains | Outperform |
| 07/18/2022 | 45.16% | Barclays | $11 → $9 | Maintains | Underweight |
| 05/23/2022 | 77.42% | RBC Capital | $15 → $11 | Maintains | Outperform |
| 04/27/2022 | 77.42% | Barclays | $14 → $11 | Maintains | Underweight |
| 01/10/2022 | 125.81% | Barclays | $11 → $14 | Maintains | Underweight |
| 12/10/2020 | 61.29% | Barclays | → $10 | Downgrades | Equal-Weight → Underweight |
| 11/24/2020 | — | BTIG | Initiates Coverage On | → Neutral | |
| 08/14/2020 | 61.29% | RBC Capital | $11 → $10 | Maintains | Outperform |
| 04/29/2020 | 45.16% | Barclays | $20 → $9 | Maintains | Equal-Weight |
| 02/25/2020 | 270.97% | RBC Capital | $21 → $23 | Maintains | Outperform |
| 10/03/2019 | 238.71% | RBC Capital | → $21 | Reinstates | → Outperform |
| 08/21/2019 | 214.52% | Credit Suisse | → $19.5 | Downgrades | Outperform → Neutral |
| 03/27/2019 | 222.58% | Nomura | → $20 | Initiates Coverage On | → Buy |
| 02/14/2019 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 10/24/2018 | 198.39% | Deutsche Bank | $19 → $18.5 | Upgrades | Hold → Buy |
| 10/12/2018 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 08/02/2018 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 06/15/2018 | 222.58% | RBC Capital | → $20 | Initiates Coverage On | → Outperform |
| 01/25/2018 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 10/10/2017 | 190.32% | Barclays | $17 → $18 | Maintains | Equal-Weight |
Chimera Investment Questions & Answers
The latest price target for Chimera Investment (NYSE: CIM) was reported by RBC Capital on October 5, 2022. The analyst firm set a price target for $7.00 expecting CIM to rise to within 12 months (a possible 12.90% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Chimera Investment (NYSE: CIM) was provided by RBC Capital, and Chimera Investment maintained their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimera Investment, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimera Investment was filed on October 5, 2022 so you should expect the next rating to be made available sometime around October 5, 2023.
While ratings are subjective and will change, the latest Chimera Investment (CIM) rating was a maintained with a price target of $11.00 to $7.00. The current price Chimera Investment (CIM) is trading at is $6.20, which is out of the analyst's predicted range.